Side effects of sorafenib and countermeasures
Administration of more than 400 mg/day of sorafenib for 1 month prolonged progression-free survival (PFS) in Japanese patients with advanced renal cell carcinoma (RCC). This indicated that it is very important to prevent and manage side effects of sorafenib avoiding drug withdrawal or dose reduction...
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 58(2012), 11 vom: 28. Nov., Seite 635-7 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , |
| Format: | Aufsatz |
| Sprache: | Japanese |
| Veröffentlicht: |
2012
|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica |
| Schlagworte: | Journal Article Antineoplastic Agents Phenylurea Compounds Niacinamide 25X51I8RD4 Sorafenib 9ZOQ3TZI87 |